GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs > Medical > Recreational

<< Previous

Bullboard Posts

Next >>

Comment by Duediligence33on Feb 21, 2017 6:07pm

109 Views

Post# 25874276

RE:Medical > Recreational

I fully agree with your assessment that medical is more profitable and as I am anti smoking
I like the gel caps with accurate dosages and the new sub lingual applications and the milling process that CMED uses

CMED with its long standing GMP status will be the go to company for conservative physicians
Baby Boomers definitley is the demographic to address with high value cannabis products
Canopy has Tweed for rec and Bedrocan for medical and Mettrum Spectrum for the in between and Aphria will have the lowest cost wholesaler market as they are efficient in their building out

I am excited for the prospects of CMED as I have seen their patient increases month over month in Novmeber 2016 and January 2017 as per the recent report of Brent Zettl
The financials on Thursday will shed more clarity

I have a large position in WEED and APH and today I have added CMED (10,000 shares) as the third leg of the stool so to speak to balance the Cannabis revolution that is currently underway and will reach great heights when legalizatiuon is finally in place in some form probably by early 2018

I predict CMED could reach $ 100 by then which is only a market cap of over 2 billion which Canopy already has NOW.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec